Research map: Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma · Ester Álvarez‐Benedicto · 2023 · 133 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement · PRISMA-P Group · 2015 · 27113 citations · Cited by this paper
  5. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy · Xueting Xia · 2024 · 99 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation · Larissa Shamseer · 2015 · 13514 citations · Cited by this paper
  8. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells · Jiangping Li · 2023 · 81 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma · Sattva Swarup Neelapu · 2017 · 6103 citations · Cited by this paper
  11. Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs · Donghui Song · 2024 · 72 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells · Cameron John Turtle · 2016 · 1025 citations · Cited by this paper
  14. CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms · Xin Zhou · 2024 · 52 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia · Bianca Santomasso · 2018 · 954 citations · Cited by this paper
  17. CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects · Mahmood Saba Choudhery · 2024 · 33 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma · Andras Attila Heczey · 2017 · 545 citations · Cited by this paper
  20. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer · Yu Cao · 2023 · 23 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers · Nisha Nagarsheth · 2021 · 342 citations · Cited by this paper
  23. In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy · Weiyue Zhang · 2024 · 20 citations · Cites this paper
  24. Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study · 2026 · Related
  25. Untitled · Cited by this paper
  26. Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival · Brittany Cucchiaro · 2024 · 19 citations · Cites this paper
  27. Untitled · Cited by this paper
  28. Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma · Ester Álvarez‐Benedicto · 2023 · 15 citations · Cites this paper
  29. Untitled · Cited by this paper
  30. Solid tumour cellular therapy — principles of toxicity management · Maximilian Julve · 2024 · 15 citations · Cites this paper
  31. Untitled · Cited by this paper
  32. The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs · Kaveh Hadiloo · 2024 · 14 citations · Cites this paper
  33. Untitled · Cited by this paper
  34. Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1+CD8+ T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer · Jing Wang · 2023 · 9 citations · Cites this paper
  35. Untitled · Cited by this paper
  36. Adoptive T Cell Therapy Targeting MAGE-A4 · Kapil Chandora · 2025 · 7 citations · Cites this paper
  37. Untitled · Cited by this paper
  38. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells · Megen C Wittling · 2024 · 4 citations · Cites this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)